Oncology-new York
译名:肿瘤学-纽约
ONCOLOGY-NEW YORK
1-3
2026
影响因子区间
—
平台估算
1%
2025
中国作者发文占比
—
收费
期刊简介:Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.
【译文】尽管实验室和临床癌症研究需要紧密相连,但基本层面的观察往往与医学应用脱节。该期刊致力于加速实验结果转化为临床应用,并将临床应用反馈到实验室进行进一步研究。这一努力的基本目的是推进与癌症相关的临床知识,并改善恶性肿瘤的预防、诊断和治疗结果。该期刊发表来自世界各地的癌症项目的重要临床研究,以及重要的转化性实验室发现、迷你综述(邀请和投稿)以及肿瘤学领域演变和有争议话题的深入讨论。该期刊的一个独特之处在于新增了一个专注于快速同行评审和随后发表1期和2期临床试验短期报告的版块,目标是确保高质量的癌症临床研究迅速进入公共领域,无论试验最终关于疗效或毒性的结论如何。
| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q4 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |